What Growth Plank Will The Phenylketonuria Treatment Market Move To In The Next 10 Years?

1
Phenylketonuria Treatment Market
Report Id PMRREP14410 Category Life Science
Healthcare
2
About Persistence Market Research
Customized Research
Persistence Market Research(Persistence Market
Research) is a premier provider of syndicated
research reports, custom research reports, and
consulting services. We deliver a complete
packaged solution, which combines current market
intelligence, statistical anecdotes, technology
inputs, valuable growth insights, aerial view of
the competitive framework, and future market
trends. We provide research services at a global
as well as regional level key regions include
GCC, ASEAN, and BRIC. Our offerings cover a broad
spectrum of industries including Chemicals,
Materials, Energy, Technology, Healthcare, and
Retail. We have a global presence with delivery
centers across India specializing in providing
global research reports and country research
reports. Persistence Market Research is
headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Syndicated Research
Investment Research
Social Media Research
Research Capabilities
Sector Coverage

• Customized Research
• Syndicated Research
• Investment Research
• Social Media Research

• Automotive and Transportation
• Electronics, Semiconductor, and ICT
• Retail and Consumer Products
• Industrial Automation and Equipment

• Chemicals Materials
• Food and Beverages
• Services and Utilities
• Energy, Mining, Oil, and Gas

Subscription Information
For detailed subscription information please
contact Website www.persistencemarketresearch.co
m For sales queries or new topics email us on
sales_at_persistencemarketresearch.com
3
What Growth Plank Will The Phenylketonuria
Treatment Market Move To In The Next 10 Years?

• Phenylketonuria (PKU) is an inherited disorder
  caused by excess of phenylalanine in the blood,
  which can lead to severe intellectual
  disabilities. There is no cure for
  phenylketonuria as yet, and dietary management is
  the only option to maintain the phenylalanine
  level in the body. Untreated infants with PKU
  tend to have unusually light eye, skin, and hair
  colour due to excess of phenylalanine levels
  interfering with melanin. Neurological symptoms
  such as seizures, abnormal muscle movement,
  tremors, or involuntary movement are some of the
  symptoms mainly observed in such patients.
• Rising prevalence of phenylketonuria among
  newborns and surging demand for novel
  formulations to treat the disease have led to
  increased opportunities for market players.
  Stakeholders are investing more in research
  development for novel treatment solutions within
  the nutraceutical industry.
• According to the latest report published by
  Persistence Market Research, the global phenylketo
  nuria treatment market for protein ingredients
  was valued at US 325.9 Mn in 2019, and is
  predicted to witness an impressive CAGR of over
  6 during the forecast period (20202030).
  Similarly, the market for finished products was
  valued at US 565.8 Mn in 2019, and is predicted
  to witness an impressive CAGR of around 7
  through 2030.

Get Sample Copy of Report _at_ https//www.persistenc
emarketresearch.com/samples/14410
4
Collaborations Acquisitions Key Strategies
amongst Market Players
Prominent players in the phenylketonuria
treatment market are firming their product ranges
through acquisitions and reaching out to emerging
markets. Increasing investments and manufacturing
capacity expansion are expected to favour growth
of the global market over the forecast
period. For instance, Mead Johnson Nutrition
Company was acquired by the Reckitt Benckiser
Group plc (RB). Mead Johnson is now a division of
RB, adding its globally-recognized brands,
including Phenyl-Free 1, an iron-fortified PKU
infant formula and medical food powder for
infants and young children with documented
phenylketonuria. Additionally, Abbott
Laboratories collaborated with Syngene to
inaugurate its first nutrition research
development centre in India. Various players in
the phenylketonuria treatment market are focusing
on research development, product launches, and
advanced solutions to strengthen and expand their
product portfolios. For instance, Vitaflo USA
introduced PKU Sphere, a powdered, low
phenylalanine medical food used in the dietary
management of phenylketonuria. The medical food
formula is a Glycomacropeptide (GMP)-based
medical food containing a balanced mix of GMP and
amino acids.
Access Full Report _at_ https//www.persistencemarket
research.com/checkout/14410
5
(No Transcript)